セールス 変化する 日付
AbbVie USD 17.4B 410M 2026-09
Acadia Pharmaceuticals USD 342M 34.04M 2026-09
Akebia Therapeutics USD 57.62M 1.14M 2025-12
ALKERMES USD 480.13M 15.88M 2026-09
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Amarin USD 49.22M 451K 2025-12
Amgen USD 10.4B 300M 2026-09
Baxter International USD 2.98B 20M 2026-09
Biogen USD 2.8B 60M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Coherus Biosciences USD 12.75M 1.18M 2025-12
Eli Lilly USD 24.4B 1.43B 2026-09
Fujifilm JPY 885.02B 58.53B 2026-09
Gilead Sciences USD 8.3B 500M 2026-09
Ironwood Pharmaceuticals USD 113.04M 6.53M 2026-06
Merck USD 18.1B 1.5B 2026-09
Myriad Genetics USD 190.7M 9.7M 2026-06
Pacira USD 176.65M 15.75M 2026-09
Perrigo USD 989M 31M 2026-09
Pfizer USD 16.6B 1.57B 2026-09
PTC Therapeutics USD 357.8M 3.2M 2026-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
Teva Pharmaceutical Industries USD 4.37B 8.3B 2026-09
Vertex Pharmaceuticals USD 3.44B 110M 2026-09
Xencor USD 116.52M 65.3M 2026-09
Zoetis USD 2.4B 100M 2026-09